INDIA MARKET LENS

Max Healthcare Institute Limited (MAXHEALTH): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Max Healthcare Institute Limited, explained in plain English.

  • Max Healthcare Institute Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
  • MAXHEALTH closed at ₹1,081.00 on 20 November 2026.
  • Over the past year the shares are down 8.5%, trading between ₹797.00 and ₹1,185.40.
  • Reported fundamentals show return on equity of 12.79%, a net margin of 15.1%, debt to equity of 32.91.
  • Our Pulse grade checklist scores it C (50/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
  • Annualised volatility over the past year is 27.08% with a maximum drawdown of -29.91% and a beta of 0.7 against NIFTY 50.
  • Recent coverage: Market winners: Max Healthcare, Deepak Fertilisers among 10 stocks that surged up to 14% in last week
  • Recent coverage: Max Healthcare among 10 Nifty stocks rallied up to 22% in 1 month. Did you miss the rally?
  • Recent coverage: Hospital stocks in focus: Max Healthcare, Aster DM, Fortis surge up to 7%

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 20 Nov 2026. Closed — weekend.

Max Healthcare Institute Limited (MAXHEALTH)

₹947.1

▲ 0.8 (+0.08%)

Price & volume

MAXHEALTH price chart, 1Y range. 252 points from 2025-11-17 to 2026-11-13. Opens at 1,121.6, closes at 947.1, ranging between 815 and 1,181.1.8009001,0001,1001,200Nov-25Jan-26Feb-26Apr-26Jun-26Aug-26Sep-26Nov-26volume

Hover for exact price & volume · green/red volume bars show up vs down days

Neutral momentum · 3/5
✓ Above 50-day avg✕ Above 200-day avgRSI 62.9 · healthyMACD positiveBollinger %B 86ADX 27.6 · strong trend

1M

+10.00%

3M

-6.53%

6M

-7.70%

1Y

-13.74%

Where it sits in its 52-week range

36%
₹815₹1,181.1

Below 52-week high

19.8%

16.2% above the low

Momentum read

Neutral

3/5 checks passed

52-wk high

₹1,181.1

52-wk low

₹815

Market cap

₹92,184 Cr

P/E (trailing)

67.0

Dividend yield

—

ROE

12.79%

Profit margin

15.1%

Revenue growth

20.3%

Price / Book

8.14

Debt / Equity

32.91

EPS (TTM)

14.13

Book value

₹116.34

Beta

0.67

Pulse grade: D, 43 out of 100

Momentum

C
  • ✓Trading above 50-day average
  • ✕Trading above 200-day average
  • ✓RSI in healthy 45-70 zone
  • ✕Positive 3-month return

Growth

F
  • ✕Revenue growth above Pharma & Healthcare median (20.8%)
  • ✓Revenue growing above 5%
  • ✕Quarterly profits trending up

Profitability

C
  • ✕Return on equity above Pharma & Healthcare median (14.56%)
  • ✓Return on equity above 12%
  • ✓Profit margin above Pharma & Healthcare median (13.82%)

Safety

D
  • ✕Debt below Pharma & Healthcare median (18.57)
  • ✓Debt not extreme for the sector
  • ✓Less volatile than the market (beta < 1.2)
  • ✕Pays a dividend

Quarterly revenue vs net profit

Revenue Net profit₹ crore, by quarter

Sep 2026: revenue ₹2,569 crore · net profit ₹415 crore · margin 16.2%

2,5690Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026

Business quality

Intrinsic value

Building the model…

Analyst coverage

Who owns this company

Events, dividends & splits

Market position

Pharma & Healthcare sector

PeerPrice ₹Day changeFrom 52-wk high
SUNPHARMA1,880-0.27%-6.05%
DRREDDY1,380-0.48%-0.48%
CIPLA1,391.8-1.17%-9.36%
DIVISLAB11,442-0.37%-1.07%
APOLLOHOSP8,526+0.13%-5.99%
LUPIN1,980.3-1.72%-21.25%

MAXHEALTH headlines

No MAXHEALTH stories right now.

MAXHEALTH filings & announcements

Reading the exchange…

MAXHEALTH, historical timeline

The timeline will be ready shortly

The rest of the page is unaffected.

Risk & return, last 12 months

Volatility (ann.)

26.26%

Sharpe ratio

-0.76

Sortino ratio

-1.04

Max drawdown

-31%

Daily VaR (95%)

-2.79%

CAGR (1Y)

-15.62%

Return skew

0.08

Sharpe/Sortino use a 7% risk-free rate. VaR-95 = the daily loss exceeded only 5% of days last year.

Risk profile over time

Quant tearsheet

Monthly returns, how deep the falls ran, and how tightly it tracks NIFTY.